Gene Therapy Slows Huntington’s by 75% in ‘Groundbreaking’ Clinical Trial
In a trial of people with early Huntington's, the newly developed therapy slowed the progression of symptoms by 75%.
In a trial of people with early Huntington's, the newly developed therapy slowed the progression of symptoms by 75%.